The U.S. Food and Drug Administration has granted approval for ANDA087081, an abbreviated new drug application for a nitrofurazone 0.2% topical solution. The product, submitted by sponsor Wendt, is classified as a TOPICAL route and comes in a SOLUTION dosage form. The submission was an original (ORIG) filing, submission number 1, and received an approved (AP) status on July 22, 1981. The product is currently marked as discontinued in the FDA records.
Key details:
- Brand name: Nitrofurazone
- Strength: 0.2%
- Route: Topical
- Dosage form: Solution
- Sponsor: Wendt
- Application number: ANDA087081
- Submission status: Approved (AP) as of 1981-07-22
- Marketing status: Discontinued
法规动态2026年9月19日•1 分钟阅读
FDA Approves Nitrofurazone Topical Solution (ANDA087081)
The FDA approved ANDA087081 for a 0.2% nitrofurazone topical solution submitted by Wendt; the product is listed as discontinued.
由 PharmaCountry 团队整理 · 来源： FDA.gov
评分
(0)
(0)
(0)
(0)
(0)
留下您的评分